20 Patents
- US125839392026Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - US125646512026Radiolabeled Anti-pd-l1 Antibodies for Immuno-pet Imaging
REGENERON PHARMACEUTICALS, Inc.
0 cites - US123898892025Mouse Having a Humanized Cluster of Differentiation 47 Gene
Regeneron Pharmaceuticals, Inc.
0 cites - US123446772025Anti-psma Antibodies, Bispecific Antigen-binding Molecules That Bind PSMA and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US122972572025Multispecific Antigen-binding Molecules and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - US121152162024Anti-human Papillomavirus (HPV) Antigen-binding Proteins and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US120704602024Methods of Treating Skin Cancer with Carboxypeptidase Vitellogenic Like (CPVL) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US120535342024Radiolabeled Anti-pd-l1 Antibodies for Immuno-pet Imaging
Regeneron Pharmaceuticals, Inc.
0 cites - US120545572024Combination of Anti-pd-1 Antibodies and Bispecific Anti-cd20/anti-cd3 Antibodies to Treat Cancer
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US119651612024Methods and Compositions for Sensitization of Tumor Cells to Immune Therapy
Regeneron Pharmaceuticals, Inc.
0 cites - US119589102024Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US119107882024Mouse Having a Humanized Cluster of Differentiation 47 Gene
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- US115595762023Anti-human Papillomavirus (HPV) Antigen-binding Proteins and Methods of Use Thereof
Regeneran Pharmaceuticals, Inc.
0 cites